SYNTHETIC BIOPSY

Welcome to the Brand page for “SYNTHETIC BIOPSY”, which is offered here for Medical products for human use that trigger expression or activation in the human body of a biomarker, compound or body response useable for prevention of diseases, cancer or other diseases related to genetic dysregulation; medical products for human use that trigger expression or activation in the human body of a biomarker, compound or body response useable for detection of diseases, cancer or other diseases related to genetic dysregulation; medical products for human use that trigger expression or activation in the human body of a biomarker, compound or body response useable for localization of diseases, cancer or other diseases related to genetic dysregulation; medical products for human use that trigger expression or activation in the human body of a biomarker, compound or body response useable for therapy of diseases, cancer or other diseases related to genetic dysregulation; medical products for animal use that trigger expression or activation in the animal body of a biomarker, compound or body response useable for prevention of diseases, cancer or other diseases related to genetic dysregulation; medical products for animal use that trigger expression or activation in the animal body of a biomarker, compound or body response useable for detection of diseases, cancer or other diseases related to genetic dysregulation; medical products for animal use that trigger expression or activation in the animal body of a biomarker, compound or body response useable for localization of diseases, cancer or other diseases related to genetic dysregulation; medical products for animal use that trigger expression or activation in the animal body of a biomarker, compound or body response useable for therapy of diseases, cancer or other diseases related to genetic dysregulation;medical services for prevention of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; medical services for detection of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; medical services for localization of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; medical services for therapy of diseases in humans based on technology focused on triggering the expression or activation in the human body of a biomarker, compound or body response usable for these medical services; medical services for prevention of diseases in animals based on technology focused on triggering the expression or activation in the animal body of a biomarker, compound or body response usable for these medical services; medical services for detection of diseases in animals based on technology focused on triggering the expression or activation in the animal body of a biomarker, compound or body response usable for these medical services; medical services for localization of diseases in animals based on technology focused on triggering the expression or activation in the animal body of a biomarker, compound or body response usable for these medical services; medical services for therapy of diseases in animals based on technology focused on triggering the expression or activation in the animal body of a biomarker, compound or body response usable for these medical services;biopsy;.

Its status is currently believed to be active. Its class is unavailable. “SYNTHETIC BIOPSY” is believed to be currently owned by “Earli Inc.”